Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
4.67B | 4.53B | 4.39B | 4.10B | 2.65B | Gross Profit |
3.54B | 3.45B | 3.29B | 3.05B | 1.83B | EBIT |
813.29M | 525.28M | 245.43M | 1.06B | 659.85M | EBITDA |
813.29M | 629.73M | 245.43M | 1.11B | 688.71M | Net Income Common Stockholders |
1.01B | 637.46M | 103.71M | 1.38B | 672.32M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
7.79B | 6.96B | 5.41B | 5.42B | 4.24B | Total Assets |
10.99B | 9.93B | 8.13B | 7.55B | 5.30B | Total Debt |
37.41M | 72.95M | 96.48M | 105.72M | 90.42M | Net Debt |
-1.31B | -1.49B | -990.35M | -957.11M | -2.15B | Total Liabilities |
2.05B | 1.91B | 1.92B | 1.77B | 1.44B | Stockholders Equity |
8.94B | 8.02B | 6.21B | 5.78B | 3.86B |
Cash Flow | Free Cash Flow | |||
1.81B | 1.47B | 1.18B | 1.46B | 1.39B | Operating Cash Flow |
1.95B | 1.60B | 1.29B | 1.61B | 1.47B | Investing Cash Flow |
-1.11B | -1.18B | -318.32M | -2.86B | -1.56B | Financing Cash Flow |
-1.03B | 60.19M | -936.94M | 34.07M | 2.05B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $2.89T | 31.30 | 30.64% | 0.81% | 15.04% | 12.38% | |
78 Outperform | $193.98B | 35.94 | 39.42% | ― | 11.02% | 4.96% | |
74 Outperform | $251.67B | 27.72 | 20.18% | 2.52% | -5.34% | -30.57% | |
74 Outperform | $2.09T | 21.17 | 30.80% | 0.36% | 13.89% | 38.99% | |
73 Outperform | $274.98B | 45.18 | 10.13% | 0.55% | 8.72% | 51.47% | |
73 Outperform | $22.64B | 23.40 | 11.31% | ― | 3.05% | 55.96% | |
59 Neutral | $22.39B | 11.53 | -18.05% | 2.31% | 5.00% | -25.89% |